Screener

Clinical trials

Name: Inhibrx Biosciences, Inc. Clinical trials by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Inhibrx Biosciences, Inc.·Business Segments·1 segment

Breakdown

Segment	FY'24	FY'25
Business Segments	$47.67M	$35.34M
Total	$47.67M	$35.34M

All segment values are derived from annual filings.

Business SegmentsView metric